In this episode of The Fellow on Call: The Heme/Onc Podcast: The Fellow on Call team shifts their focus from ER+ to HER+ breast cancer. The group details:
- What is HER2?
- What is the mechanism of HER2?
- The discovery of trastuzumab
- The use of trastuzumab in adjuvant and neoadjuvant settings
- Highlights of key trials that shape the paradigm of management
- And much more